Drug data last refreshed 9h ago · AI intelligence enriched 6d ago
Chorionic gonadotropin (hCG) is a recombinant or urinary-derived gonadotropin used primarily in fertility treatment to stimulate ovulation in women and testosterone production in men. It mimics the natural hormone that triggers reproductive function during the menstrual cycle and pregnancy.
With LOE approaching, this product likely has a smaller commercial team focused on lifecycle management and defending market position against generics and biosimilars.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine Disorders
Comparative Bioavailability Study of Human Chorionic Gonadotropin (hCG)-IBSA Versus a Marketed hCG Formulation
A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation
Administration of Follicle-stimulating Hormone (FSH) and Low Dose Human Chorionic Gonadotropin (hCG) for Oocyte Maturity While Decreasing hCG Exposure in In Vitro Fertilization (IVF) Cycles
HCG (Human Chorionic Gonadotropin) Priming for Thin Endometrium in IVF (in Vitro Fertilization)
Worked on CHORIONIC GONADOTROPIN at Ferring Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on chorionic gonadotropin offers limited growth potential but provides deep expertise in a specialized therapeutic area (reproductive endocrinology) and biosimilar/generic dynamics. This is a career move best suited for professionals interested in mature-market expertise, managed care navigation, and competitive positioning rather than launch excitement or pipeline advancement.